Novel technologies to detect minimal residual disease (MRD)
Todd E. Druley
Developments in prognostic factors of acute myeloid leukemia (AML)
Gert J. Ossenkoppele
Ponatinib and its role in treating ALL
How to manage AML in pregnancy
Evolving CLL treatments: creating choices and igniting discussions
Deborah Henderson et al.